Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Everolimus Versus Placebo in Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Everolimus Versus Placebo in Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01111058).
- Everolimus With and Without Temozolomide in Adult Low Grade Glioma: Complete Statistical AnalysisIndependent statistical analysis of Everolimus With and Without Temozolomide in Adult Low Grade Glioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02023905).
- Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy: Complete Statistical AnalysisIndependent statistical analysis of Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- EVERZOTAIndependent statistical analysis of Efficacy of Everolimus-Eluting Versus Zotarolimus-Eluting Sten for Coronary Lesions in Acute Myocardial Infarction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- EVIDENCEIndependent statistical analysis of A Study Examining the Effects of Nebivolol Compared to Atenolol on Endothelial Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evidence-based Intervention for Improved Head Impact Safety in Youth Football – Aim 1 and Aim 3: Complete Statistical AnalysisIndependent statistical analysis of Evidence-based Intervention for Improved Head Impact Safety in Youth Football - Aim 1 and Aim 3: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- EVITAIndependent statistical analysis of 24 Months Follow-up, Two Arm Study to Compare the Cardiovascular Profile in a Regimen With Everolimus + Mycophenolic Acid (MPA) Versus (vs.) a Regimen of CNI+MPA in Maintenance…
- EvKIndependent statistical analysis of Etomidate Versus Ketamine for Emergency Endotracheal Intubation: a Prospective Randomized Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- EVOGUARDIndependent statistical analysis of Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- EVOKEIndependent statistical analysis of Safety and Efficacy Study of the Evoke™ SCS System With Feedback vs. Conventional Stimulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- EVOKE-01Independent statistical analysis of Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- EVOLVEIndependent statistical analysis of Epanova® for Lowering Very High Triglycerides: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01242527).
- EVOLVEIndependent statistical analysis of E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- EW-DIndependent statistical analysis of A Community Wellness Program for Adults Living With Long-term Physical Disability: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EWISE: Study of Eplerenone in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia: Complete Statistical AnalysisIndependent statistical analysis of EWISE: Study of Eplerenone in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- EX-ODCKDIndependent statistical analysis of Exercise in Obese Diabetic Patients With Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01036490).
- Examination of the Effectiveness of Suvorexant in Improving Daytime Sleep in Shift Workers: Complete Statistical AnalysisIndependent statistical analysis of Examination of the Effectiveness of Suvorexant in Improving Daytime Sleep in Shift Workers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Examination of the Effects of Chromium Levels on Glucose Metabolism, Lipid Metabolism, Morbidity and Mortality Rates in Patients Followed in Intensive Care Unit: Complete Statistical AnalysisIndependent statistical analysis of Examination of the Effects of Chromium Levels on Glucose Metabolism, Lipid Metabolism, Morbidity and Mortality Rates in Patients Followed in Intensive Care Unit: primary endpoint results, effect estimate…
- Examining Brain Responses Linked to Emotion in Individuals Who Smoke Cigarettes: Complete Statistical AnalysisIndependent statistical analysis of Examining Brain Responses Linked to Emotion in Individuals Who Smoke Cigarettes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease: Complete Statistical AnalysisIndependent statistical analysis of Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Examining How a Facilitated Self-Sampling Intervention and Testing Navigation Intervention Influences COVID-19 Testing: Complete Statistical AnalysisIndependent statistical analysis of Examining How a Facilitated Self-Sampling Intervention and Testing Navigation Intervention Influences COVID-19 Testing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Examining the Impact of Family Connectors: Complete Statistical AnalysisIndependent statistical analysis of Examining the Impact of Family Connectors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05195489).
- Examining the Impact of Sirolimus on Ketamine’s Antidepressant Effects: Complete Statistical AnalysisIndependent statistical analysis of Examining the Impact of Sirolimus on Ketamine's Antidepressant Effects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02487485).
- Examining Tolerance to CNS Stimulants in ADHD: Complete Statistical AnalysisIndependent statistical analysis of Examining Tolerance to CNS Stimulants in ADHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02039908).
- EXCAAPEIndependent statistical analysis of Trial of Rad-223 Activity in Asymptomatic Patients With mCRPC While on Abiraterone or Enzalutamide Besides AR-V7 Status: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- EXCHANGEIndependent statistical analysis of E-Cigarettes and Financial Incentives to Promote Tobacco Harm Reduction Among Adults Accessing Shelter Services: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Exercise and Markers of Medial Temporal Health in Youth At-risk for Psychosis: Complete Statistical AnalysisIndependent statistical analysis of Exercise and Markers of Medial Temporal Health in Youth At-risk for Psychosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Exercise and QUality Diet After Leukemia: The EQUAL Study: Complete Statistical AnalysisIndependent statistical analysis of Exercise and QUality Diet After Leukemia: The EQUAL Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02244411).
- Exercise Dose and Metformin for Vascular Health in Metabolic Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Exercise Dose and Metformin for Vascular Health in Metabolic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03355469).
- Exercise From Afar: Progressing At Risk Individuals to Independent Exercise: Complete Statistical AnalysisIndependent statistical analysis of Exercise From Afar: Progressing At Risk Individuals to Independent Exercise: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06667817).
- Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan: Complete Statistical AnalysisIndependent statistical analysis of Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Exercise Intervention to Reduce Postural Instability in Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of Exercise Intervention to Reduce Postural Instability in Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00708734).
- Exercise Into Pain in Chronic Rotator Cuff Related Shoulder Pain: a Prospective Single-Group Feasibility Study: Complete Statistical AnalysisIndependent statistical analysis of Exercise Into Pain in Chronic Rotator Cuff Related Shoulder Pain: a Prospective Single-Group Feasibility Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Exercise Pulmonary Transit Time: Complete Statistical AnalysisIndependent statistical analysis of Exercise Pulmonary Transit Time: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04336995).
- ExerciZzzIndependent statistical analysis of Exercise, Sleep Quality and Nocturnal Fat Oxidation in Metabolic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04105218).
- EXIST-1Independent statistical analysis of Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1): primary endpoint results, effect estimate with…
- EXIST-3Independent statistical analysis of A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures: primary endpoint…
- Exjade-Early-Trial: Complete Statistical AnalysisIndependent statistical analysis of Exjade-Early-Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01058369).
- Expanded Controlled Study of Safety and Efficacy of MCI-186 in Patients With Amyotrophic Lateral Sclerosis (ALS): Complete Statistical AnalysisIndependent statistical analysis of Expanded Controlled Study of Safety and Efficacy of MCI-186 in Patients With Amyotrophic Lateral Sclerosis (ALS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Expansion Trial for Axitinib In Head And Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Expansion Trial for Axitinib In Head And Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02762513).
- Exparel vs. Standard Bupivicaine for Abdominoplasty: Complete Statistical AnalysisIndependent statistical analysis of Exparel vs. Standard Bupivicaine for Abdominoplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01853176).
- EXPECTIndependent statistical analysis of Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size…
- EXPEDITION-4Independent statistical analysis of A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Renally Impaired Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection: primary endpoint results, effect…
- Experimental Dentifrice Remineralization/Fluoride Uptake in an in Situ Model: Complete Statistical AnalysisIndependent statistical analysis of Experimental Dentifrice Remineralization/Fluoride Uptake in an in Situ Model: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00752089).
- Explorative Trial Evaluating the Efficacy and Tolerability of LEO43204 in Moderate to Severe Acne: Complete Statistical AnalysisIndependent statistical analysis of Explorative Trial Evaluating the Efficacy and Tolerability of LEO43204 in Moderate to Severe Acne: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Exploratory Clinical Study to Investigate the Ability of an Experimental Combination Dentifrice to Protect Sensitive Teeth: Complete Statistical AnalysisIndependent statistical analysis of Exploratory Clinical Study to Investigate the Ability of an Experimental Combination Dentifrice to Protect Sensitive Teeth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With ADHD: Complete Statistical AnalysisIndependent statistical analysis of Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With ADHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Exploratory Study for Toivoa-001 on Human Factors: Complete Statistical AnalysisIndependent statistical analysis of Exploratory Study for Toivoa-001 on Human Factors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06477913).
- Exploratory Study of OPC-12759 Ophthalmic Suspension: Complete Statistical AnalysisIndependent statistical analysis of Exploratory Study of OPC-12759 Ophthalmic Suspension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01493180).